NexGel, Inc.
NXGLNexGel, Inc. is a specialized manufacturer of high water content, electron beam cross-linked aqueous polymer hydrogels used in wound care, medical diagnostics, drug delivery, and cosmetics.
Table of contents
Earnings
Next report
Aug 11, 2026 (in a month)Competitors
By market cap
By revenue growth
Profile
NexGel, Inc. is a specialized manufacturer of high water content, electron beam cross-linked aqueous polymer hydrogels used in wound care, medical diagnostics, drug delivery, and cosmetics. The company leverages proprietary manufacturing technologies to produce custom gels with precise physical characteristics without the use of chemical cross-linking agents. Its business model encompasses contract manufacturing for third parties, a branded consumer product portfolio, and the development of advanced medical devices.
NexGel is one of only two manufacturers globally utilizing electron beam technology for high-performance hydrogels, creating a high barrier to entry through proprietary manufacturing processes and FDA-compliant facilities.
Questions, answered.
- What is NexGel, Inc.'s market cap?
- NexGel, Inc. (NXGL) has a market capitalization of $4.7M and trades on NASDAQ.
- Who are NexGel, Inc.'s competitors?
- NexGel, Inc.'s key competitors include 3M Healthcare, Johnson & Johnson, Pfizer Consumer Healthcare, and others. These companies compete in similar markets and product categories.
- Who does NexGel, Inc. partner with?
- NexGel, Inc.'s notable partners include CG Laboratories, Inc., Noble Fiber Technologies, Berry Global, Inc., and others.
- What subsidiaries does NexGel, Inc. have?
- NexGel, Inc.'s subsidiaries include CG Converting and Packaging, LLC.
- Where is NexGel, Inc. headquartered?
- NexGel, Inc. is headquartered in United States of America and employs approximately 19 people. It has been publicly traded since 2021.